Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Node Positive HER2 Negative Breast Cancer
Interventions: OTHER: Placebo|DRUG: Aspirin
Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)|United States Department of Defense|Bayer|Canadian Cancer Trials Group